Various unapproved and improperly labeled drug products that were marketed, sold, and distributed via the internet by Flawless Beauty LLC, of Asbury Park, New Jersey, have been seized by U.S. Marshals at the request of the FDA and the U.S. Attorney for the District of New Jersey. These products, including injectable drug products, were marketed, sold and distributed to individuals, retail outlets, health spas, and clinics.
The seized products include Relumins Advanced Glutathione “kits” and Tatiomax Glutathione Collagen Whitening “kits.” The seized products were marketed on websites including, but not limited to, www.flawlessbeautyandskin.com and www.relumins.com.
Many of the injectable products also include claims to treat scurvy, degenerative brain and liver diseases, and “alcoholic liver diseases.” The New Jersey Department of Health and Senior Services detained the unapproved injectable drug products located at Flawless Beauty.
None of these products have been proven safe or effective for their intended uses. In addition, unapproved injectable products are of concern because their quality, safety, and efficacy have not been reviewed. Further, improper injection practices may result in serious injury, including the transmission of disease.
See the FDA Announcement
See also Medical Law Perspectives, September 2012 Report: Cosmetic Surgery Gone Wrong: High Hopes Meet Unexpected Results
See also Medical Law Perspectives, May 2013 Report: Drugs, Dosage, and Damage: Physician Liability for Prescribing or Administering Medication
See also Medical Law Perspectives, April 2013 Report: Complementary and Alternative Medicine: Practitioner Liability